Given that MMP9 has been proposed as a prognostic and diagnostic marker in glioma22,25,34, our observations that MUC4 was at least as efficient as MMP9 in discrimination between grades indicates it may act as a biomarker in glioma diagnosis (Fig. 1C). The gene discussed is MUC4; the disease is central nervous system cancer.